摘要 : Platelet GPIIb/IIIa antagonists are not only used to prevent platelet aggregation, but also in combination with thrombolytic agents for the treatment of coronary thrombi. Recent data indicate a potential of abciximab alone to diss... 展开
作者 | Moser M Bertram U Peter K Bode C Ruef J |
---|---|
作者单位 | |
期刊名称 | 《Journal of Cardiovascular Pharmacology》 |
总页数 | 7 |
语种/中图分类号 | 英语 / R96 |
关键词 | abciximab Blood Platelets GPIIb/IIIa eptifibatide tirofiban 血小板 |
馆藏号 | N2007EPST0002202 |